AB
Abivax S.A.
ABVX · NASDAQ
$105.04 -1.68% (-$1.80)
1M -9.57%
Market Cap 6.72B €
P/E Ratio -
Div. Yield -
ROE 234.31%
Bulios Fair Price
$63.15
39.9% downside
Trenutna cena
$105.04
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ABVX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/B 14.76x
EV/EBITDA N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 298.52%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 234.31%
ROA 57.54%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 8.75x
Int. coverage -10.60x
Debt/Equity 0.07x
Stability
39 /100
Moderate EPS volatility 43.22%
Profitable years 0
Beta -0.25x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ABVX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Marc de Garidel
Employees
80
Headquarters
Paris